MHRA Drug Safety Update February 2021

MHRA Drug Safety Update February 2021

February 18, 2021

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 7 February 2021) has been published and includes articles on:

  • Ulipristal acetate 5mg (Esmya): further restrictions due to risk of serious liver injury
  • Pregabalin (Lyrica): reports of severe respiratory depression
  • Alkindi (hydrocortisone granules): risk of acute adrenal insufficiency in children when switching from hydrocortisone tablet formulations to granules
  • Medicines in pregnancy and breastfeeding: new initiative for consistent guidance; report on optimising data for medicines used during pregnancy
  • COVID-19 vaccines and medicines: updates for February 2021
  • Letters and drug alerts sent to healthcare professionals in January 2021 

To see the latest MHRA Drug Safety Updates in full, visit the website

Posted in: ,

More Latest News >

Briefing MPs on COVID-19 costs

PSNC is continuing its work to brief Parliamentarians on the financial pressures facing community pharmacies. Ahead of the Budget, PSNC...

No Smoking Day 2021

No Smoking Day is a national campaign that encourages the nation’s smokers to make a quit attempt on the second...

PEPS payments information

Contractors signed up to the Pharmacy Earlier Payments Scheme (PEPS) will have received their payments on 1 March directly from...